4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-000586
Chief Executive Officer gave up 85,254 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2018-12-29 | Shares withheld for taxes | −42,920 | $1.66 | $71,247 | 1,223,143 | D |
| Cooper Laurence James Neil Chief Executive Officer | 2018-12-30 | Shares withheld for taxes | −26,178 | $1.66 | $43,455 | 1,196,965 | D |
| Cooper Laurence James Neil Chief Executive Officer | 2018-12-31 | Shares withheld for taxes | −16,156 | $1.87 | $30,212 | 1,180,809 | D |
Loading xslF345X03/doc4.xml…